Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Thorsten Voss"'
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0253401 (2021)
The field of liquid biopsy has seen extensive growth in recent decades, making it one of the most promising areas in molecular diagnostics. Circulating cell-free DNA (ccfDNA) especially is used as an analyte in a growing number of diagnostic assays.
Externí odkaz:
https://doaj.org/article/96d40d8b53b2441486b66819fc19b795
Publikováno v:
Cancer Research. 83:780-780
Introduction: Circulating cell-free DNA (ccfDNA) is used as an analyte in liquid biopsy-based cancer research with promising applications in the fields of cancer screening, therapeutic decision making and monitoring and minimal residual disease contr
Autor:
Daniel Grölz, Thorsten Voss, Uwe Oelmüller, Markus Sprenger-Haussels, Kalle Guenther, Martin Schlumpberger, Siegfried Hauch
Publikováno v:
Current Pathobiology Reports
Purpose of Review Liquid biopsy analyses based on circulating cell-free nucleic acids, circulating tumor cells or other diseased cells from organs, and exosomes or other microvesicles in blood offer new means for non-invasive diagnostic applications.
Autor:
Thorsten Voß
Publikováno v:
Zeitschrift für Bankrecht und Bankwirtschaft. 30:305-321
Zusammenfassung Im Wertpapierprospektrecht steht eine neue Ära bevor: Die EU-ProspektVO, die keiner weiteren Umsetzung durch die nationalen Gesetzgeber der Mitgliedstaaten bedarf, tritt am 21. 7. 2019 in vollem Umfang in Kraft. Mit dem Gesetz zur Au
Autor:
Matthäus Majewski, Patrick Ostheim, Michael Abend, Julian Haupt, Thorsten Voss, Matthias Port, Andreas Lamkowski
Publikováno v:
Radiation research. 192(2)
Radiological exposure scenarios involving large numbers of people require a rapid and high-throughput method to identify the unexposed, and those exposed to low- and high-dose radiation. Those with high-dose exposure, e.g., >2 Gy and depending on hos
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0253401 (2021)
PLoS ONE
PLoS ONE
The field of liquid biopsy has seen extensive growth in recent decades, making it one of the most promising areas in molecular diagnostics. Circulating cell-free DNA (ccfDNA) especially is used as an analyte in a growing number of diagnostic assays.
Autor:
Tom Braegelmann, Markus Kaulartz, Thorsten Ammann, Simon Apel, Astrid Auer-Reinsdorff, Benjamin Bäßler, Philipp Behrendt, Stefan Brink, Julia Buttlar, Johannes Döveling, Donata Enzberg, Martin Fries, Tina Gausling, Isabel J. Groß-Karrais, Caroline Heinickel, Katja Hinz, Michael R.A. Huth, Dennis-Kenji Kipker, Sven J. Körner, Falco Kreis, Christina-Maria Leeb, Martin Lose, Jan Geert Meents, Florian Möslein, Sven Müller, Thomas Nägele, Boris P. Paal, Amadeus Peters, Fritz-Ulli Pieper, Philipp Plog, Philipp Reusch, Annabelle Reuter, Thomas Riehm, Giesela Rühl, Fiona Savary, Stefan C. Schicker, Charlotte Schildt, Martin Schmidt-Kessel, Tim Schröder, Hendrik Skistims, Oliver Stiemerling, Lea Tochtermann, Monika Valkanova, Thorsten Voß, Axel Walter, Maren Kristin Wöbbeking, Johannes Zwerschke, Carlo Piltz, Tom H. Braegelmann
Zum Inhalt: Künstliche Intelligenz und Maschinelles Lernen sind Technologien, die unser Zeitalter prägen werden. Das Rechtshandbuch erörtert nach einer Einführung in die technischen Hintergründe ausgewählte Themen für die Rechtspraxis, insbeso
Publikováno v:
Studies in health technology and informatics. 238
The "research apartment Halberstadtstraße" (HSS) in Braunschweig, Germany, is the attempt to realize a personal living environment as a room for diagnostics and therapy with the support of health-enabling and ambient assistive technologies (HEAAT).
Autor:
Bernd Schmidt, Stephan Eisenmann, Michael Fleischhacker, Thorsten Voss, Andrea Ullius, Dana Reinicke, Erkan Arslan
Publikováno v:
Cancer Research. 79:1386-1386
Introduction In June 2016, the FDA approved the first blood-based genetic test to detect gene mutations of epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC). With this move, the genetic characterization of cell-free DNA be